Shares of Zydus Lifesciences rose 2 percent in early trade on March 14 after the company launched cancer drug Olaparib, a PARP inhibitor, under the brand name IBYRA in India. At 9:20am ...

Zydus Cadila launched Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar and a highly effective drug for treating both Early and Advanced HER2 positive Breast Cancer ...